A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine

Authors :: Michael L. Lim
Ernest R Lanier
Lisa L. Ross
Peter Gerondelis
Elizabeth G Rouse
Robin Dretler
Source :: AIDS. 20:787-789
Publication Year :: 2006
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2006.

Subjects :: Reverse-transcriptase inhibitor
biology
business.industry
Immunology
Lamivudine
medicine.disease
biology.organism_classification
Nucleotidyltransferase
Virology
Reverse transcriptase
Infectious Diseases
Acquired immunodeficiency syndrome (AIDS)
Immunology and Allergy
Medicine
Viral disease
business
Sida
Didanosine
medicine.drug

Tools